These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18716676)

  • 21. Modelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination.
    Irvine MA; Reimer LJ; Njenga SM; Gunawardena S; Kelly-Hope L; Bockarie M; Hollingsworth TD
    Parasit Vectors; 2015 Oct; 8():547. PubMed ID: 26489753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Technical measures of filariasis elimination in Tengzhou City].
    Ma XW; Zhang XQ; Xu YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):232-4. PubMed ID: 12568031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical treatment of lymphatic filariasis].
    Hovette P; Laroche R; Verrot D; Molinier S; Touze JE
    Med Trop (Mars); 1991; 51(1):87-90. PubMed ID: 2072855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis.
    Pedersen EM; Stolk WA; Laney SJ; Michael E
    Trends Parasitol; 2009 Jul; 25(7):319-27. PubMed ID: 19559649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of the eosinophil counts in the biological diagnosis of lymphatic filariasis in French Polynesia.
    Musso D; Vialette V
    Med Mal Infect; 2012 Dec; 42(12):585-90. PubMed ID: 23116705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
    Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis.
    Adinarayanan S; Critchley J; Das PK; Gelband H
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD003758. PubMed ID: 17253495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis.
    Norman RA; Chan MS; Srividya A; Pani SP; Ramaiah KD; Vanamail P; Michael E; Das PK; Bundy DA
    Epidemiol Infect; 2000 Jun; 124(3):529-41. PubMed ID: 10982078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albendazole for lymphatic filariasis.
    Critchley J; Addiss D; Gamble C; Garner P; Gelband H; Ejere H;
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003753. PubMed ID: 16235339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions.
    Michael E; Malecela-Lazaro MN; Maegga BT; Fischer P; Kazura JW
    Trends Parasitol; 2006 Nov; 22(11):529-35. PubMed ID: 16971182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
    Wamae CN; Mwandawiro C; Wambayi E; Njenga S; Kiliku F
    East Afr Med J; 2001 Nov; 78(11):595-603. PubMed ID: 12219966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.
    Xavier A; Oliveira H; Aguiar-Santos A; Barbosa Júnior W; da Silva E; Braga C; Bonfim C; Medeiros Z
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007836. PubMed ID: 31765388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmission dynamics of diurnally subperiodic lymphatic filariasis transmitted by Ochlerotatus (Finlaya) niveus in the Andaman & Nicobar Islands.
    Shriram AN; Krishnamoorthy K; Sehgal SC
    Indian J Med Res; 2008 Jan; 127(1):37-43. PubMed ID: 18316851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.
    Mwakitalu ME; Malecela MN; Pedersen EM; Mosha FW; Simonsen PE
    Acta Trop; 2013 Dec; 128(3):692-700. PubMed ID: 24135628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    Clin Infect Dis; 2021 Sep; 73(6):994-1002. PubMed ID: 33728462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.